SlideShare a Scribd company logo
1 of 34
Quality by Design Development, optimization and robustness by Design Mayank
Global initiatives
Global initiatives References 1. ICH, Q8(R1) Pharmaceutical Development (Geneva, Switzerland, Nov. 10, 2005; Rev. 2008).  2. ICH, Q9 Quality Risk Management (Geneva, Switzerland, Nov. 9. 2005).  3. J. Agalloco et al., "FDA's Guidance for Industry: Process Validation: General Principles and Practices," presented at PDA, Jan. 14, 2009.  4. FDA, Draft Guidance for Industry—Process Validation: General Principles and Practices (Rockville, MD, Nov. 2008).  5. W. Charlton, T. Ingallinera, and D. Shive, "Validation of Clinical Manufacturing," and Validation Chapter, in Validation of Pharmaceutical Process, J. Agalloco and F. Carleton, eds. (Informa Healthcare, New York, 3rd ed., 2008), pp. 542–544.
Quality by design (QbD) What is QbD? Product and process performance characteristics are scientifically designed to meet specific objectives, not merely empirically derived from performance of test batches Focus during development Critical Quality Attributes (CQA) eg.     USP DSP ,[object Object]
Cell count
Titre
Product characteristics (egGlycocylation)
Impurity profile
Overall purity
Type of impurity (eg HCP, endotoxins, DNA,)
Yield Critical Process Parameter (CPP) ,[object Object]
Media selectivity
Media particle size
Dynamic capacity
Buffer conditions (eg pH, conductivity)
Temperature
Flow rate
Sample load
Temperature
pH
Agitation
DO
Medium composition
Osmolarity
Feed type
Process type (eg Batch, fed batch or perfustion),[object Object]
Biologists
Analysts
Chemists
Industrial pharmacist
SatiationsAnalytical equipments ,[object Object]
NIR detectors
Methanol sensors
CO2/O2 probes

More Related Content

What's hot

Statistical process control
Statistical process controlStatistical process control
Statistical process controlsandesh shah
 
Six System Inspection Model.pptx
Six System Inspection Model.pptxSix System Inspection Model.pptx
Six System Inspection Model.pptxVIJAYAVICHARE
 
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenteralsceutics1315
 
Validation utility system
Validation utility systemValidation utility system
Validation utility systemArpitSuralkar
 
Statistical Process Control (SPC) - QMS.pptx
Statistical Process Control (SPC) - QMS.pptxStatistical Process Control (SPC) - QMS.pptx
Statistical Process Control (SPC) - QMS.pptxARUN KUMAR
 
Auditing for Sterile Production Area
Auditing for Sterile Production AreaAuditing for Sterile Production Area
Auditing for Sterile Production AreaMANIKANDAN V
 
Air Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptx
Air Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptxAir Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptx
Air Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptxBhumiSuratiya
 
Role of quality systems and audits in pharmaceutical manufacturing environment
Role of quality systems and audits in pharmaceutical manufacturing environmentRole of quality systems and audits in pharmaceutical manufacturing environment
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
 
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. AmsavelDr. Amsavel A
 
Quality metrics
Quality metricsQuality metrics
Quality metricsDhruvi50
 
corrective and preventive action (CAPA)
corrective and preventive action (CAPA)corrective and preventive action (CAPA)
corrective and preventive action (CAPA)prakhar rai pk
 
Qualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri SoniQualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri SoniMayuri Soni
 
Audit of vendors and Production department
Audit of vendors and Production department Audit of vendors and Production department
Audit of vendors and Production department PUNEET NIRMAL
 

What's hot (20)

Statistical process control
Statistical process controlStatistical process control
Statistical process control
 
Six System Inspection Model.pptx
Six System Inspection Model.pptxSix System Inspection Model.pptx
Six System Inspection Model.pptx
 
Ipqc for parenterals
Ipqc for parenteralsIpqc for parenterals
Ipqc for parenterals
 
Validation utility system
Validation utility systemValidation utility system
Validation utility system
 
OHSAS guideline
OHSAS guideline OHSAS guideline
OHSAS guideline
 
Statistical Process Control (SPC) - QMS.pptx
Statistical Process Control (SPC) - QMS.pptxStatistical Process Control (SPC) - QMS.pptx
Statistical Process Control (SPC) - QMS.pptx
 
Validation of hvac system
Validation of hvac systemValidation of hvac system
Validation of hvac system
 
Auditing for Sterile Production Area
Auditing for Sterile Production AreaAuditing for Sterile Production Area
Auditing for Sterile Production Area
 
change control
change controlchange control
change control
 
Cleaning validation
Cleaning validationCleaning validation
Cleaning validation
 
Air Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptx
Air Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptxAir Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptx
Air Based Hazards, M.pharm, sem 2,Bhumi Suratiya,.pptx
 
Role of quality systems and audits in pharmaceutical manufacturing environment
Role of quality systems and audits in pharmaceutical manufacturing environmentRole of quality systems and audits in pharmaceutical manufacturing environment
Role of quality systems and audits in pharmaceutical manufacturing environment
 
Product Quality Review_APQR_Dr. A. Amsavel
Product  Quality Review_APQR_Dr. A. AmsavelProduct  Quality Review_APQR_Dr. A. Amsavel
Product Quality Review_APQR_Dr. A. Amsavel
 
Computer system validations
Computer system validationsComputer system validations
Computer system validations
 
Quality metrics
Quality metricsQuality metrics
Quality metrics
 
corrective and preventive action (CAPA)
corrective and preventive action (CAPA)corrective and preventive action (CAPA)
corrective and preventive action (CAPA)
 
Qualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri SoniQualification of laboratory equipments by Mayuri Soni
Qualification of laboratory equipments by Mayuri Soni
 
Process deviation
Process deviationProcess deviation
Process deviation
 
Presentation on QRM_NS
Presentation on QRM_NSPresentation on QRM_NS
Presentation on QRM_NS
 
Audit of vendors and Production department
Audit of vendors and Production department Audit of vendors and Production department
Audit of vendors and Production department
 

Viewers also liked

Q iwg q&a-r4_ step4 nov.2010
Q iwg q&a-r4_ step4 nov.2010Q iwg q&a-r4_ step4 nov.2010
Q iwg q&a-r4_ step4 nov.2010Pharmaguideline
 
Service design for networked business models - presentation at Service Design...
Service design for networked business models - presentation at Service Design...Service design for networked business models - presentation at Service Design...
Service design for networked business models - presentation at Service Design...Claro Partners Inc.
 
Refactoring for Design Smells - ICSE 2014 Tutorial
Refactoring for Design Smells - ICSE 2014 TutorialRefactoring for Design Smells - ICSE 2014 Tutorial
Refactoring for Design Smells - ICSE 2014 TutorialTushar Sharma
 
AMIT - QbD, a case study
AMIT - QbD, a case studyAMIT - QbD, a case study
AMIT - QbD, a case studyAmit Mukharya
 
olanzapine solid dispersion
olanzapine solid dispersion olanzapine solid dispersion
olanzapine solid dispersion Aparna Rajeevi
 
Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...
 Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam... Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...
Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...Ajinkya Nikam
 
DOE Applications in Process Chemistry Presentation
DOE Applications in Process Chemistry PresentationDOE Applications in Process Chemistry Presentation
DOE Applications in Process Chemistry Presentationsaweissman
 
Analytical quality by design
Analytical quality by designAnalytical quality by design
Analytical quality by designAnnalisa Forlenza
 
Solid dispersion as a technique for enhancement of
Solid dispersion as a technique for enhancement ofSolid dispersion as a technique for enhancement of
Solid dispersion as a technique for enhancement ofBaliram Musale
 
poorly soluble drugs and solid dispersions
poorly soluble drugs and solid dispersionspoorly soluble drugs and solid dispersions
poorly soluble drugs and solid dispersionsrcdreddi
 
Pharmaceutical Quality by Design: Review of Progress and Challenges
Pharmaceutical Quality by Design: Review of Progress and ChallengesPharmaceutical Quality by Design: Review of Progress and Challenges
Pharmaceutical Quality by Design: Review of Progress and ChallengesAjaz Hussain
 
Quality by design for Pharmaceutical Industries: An introduction
Quality by design for Pharmaceutical Industries: An introductionQuality by design for Pharmaceutical Industries: An introduction
Quality by design for Pharmaceutical Industries: An introductionCovello Luca
 
yeni ürün ve yeni pazarlara giriş stratejileri
yeni ürün ve yeni pazarlara giriş stratejileriyeni ürün ve yeni pazarlara giriş stratejileri
yeni ürün ve yeni pazarlara giriş stratejileriDoğan Say
 

Viewers also liked (20)

Quality by Design
Quality by DesignQuality by Design
Quality by Design
 
Quality-by-Design by chattar
Quality-by-Design by chattarQuality-by-Design by chattar
Quality-by-Design by chattar
 
Quality by Design : Design of experiments
Quality by Design : Design of experimentsQuality by Design : Design of experiments
Quality by Design : Design of experiments
 
Qbd by Anthony Melvin Crasto for API
Qbd by Anthony Melvin Crasto for APIQbd by Anthony Melvin Crasto for API
Qbd by Anthony Melvin Crasto for API
 
Q iwg q&a-r4_ step4 nov.2010
Q iwg q&a-r4_ step4 nov.2010Q iwg q&a-r4_ step4 nov.2010
Q iwg q&a-r4_ step4 nov.2010
 
Service design for networked business models - presentation at Service Design...
Service design for networked business models - presentation at Service Design...Service design for networked business models - presentation at Service Design...
Service design for networked business models - presentation at Service Design...
 
Refactoring for Design Smells - ICSE 2014 Tutorial
Refactoring for Design Smells - ICSE 2014 TutorialRefactoring for Design Smells - ICSE 2014 Tutorial
Refactoring for Design Smells - ICSE 2014 Tutorial
 
AMIT - QbD, a case study
AMIT - QbD, a case studyAMIT - QbD, a case study
AMIT - QbD, a case study
 
olanzapine solid dispersion
olanzapine solid dispersion olanzapine solid dispersion
olanzapine solid dispersion
 
Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...
 Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam... Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...
Enhancement of Solubility By Solid Dispersion- Presented By Mr.Ajinkya Nikam...
 
Network design - Topology
Network design  - TopologyNetwork design  - Topology
Network design - Topology
 
DOE Applications in Process Chemistry Presentation
DOE Applications in Process Chemistry PresentationDOE Applications in Process Chemistry Presentation
DOE Applications in Process Chemistry Presentation
 
Analytical quality by design
Analytical quality by designAnalytical quality by design
Analytical quality by design
 
Solid dispersion as a technique for enhancement of
Solid dispersion as a technique for enhancement ofSolid dispersion as a technique for enhancement of
Solid dispersion as a technique for enhancement of
 
poorly soluble drugs and solid dispersions
poorly soluble drugs and solid dispersionspoorly soluble drugs and solid dispersions
poorly soluble drugs and solid dispersions
 
Pharmaceutical Quality by Design: Review of Progress and Challenges
Pharmaceutical Quality by Design: Review of Progress and ChallengesPharmaceutical Quality by Design: Review of Progress and Challenges
Pharmaceutical Quality by Design: Review of Progress and Challenges
 
Quality by Design
Quality by DesignQuality by Design
Quality by Design
 
Quality by design for Pharmaceutical Industries: An introduction
Quality by design for Pharmaceutical Industries: An introductionQuality by design for Pharmaceutical Industries: An introduction
Quality by design for Pharmaceutical Industries: An introduction
 
yeni ürün ve yeni pazarlara giriş stratejileri
yeni ürün ve yeni pazarlara giriş stratejileriyeni ürün ve yeni pazarlara giriş stratejileri
yeni ürün ve yeni pazarlara giriş stratejileri
 
MARKA OLUSTURMAK
MARKA OLUSTURMAKMARKA OLUSTURMAK
MARKA OLUSTURMAK
 

Similar to Quality By Design

DOE in Pharmaceutical and Analytical QbD.
DOE in  Pharmaceutical and Analytical QbD.DOE in  Pharmaceutical and Analytical QbD.
DOE in Pharmaceutical and Analytical QbD.SALMA RASHID SHAIKH
 
Design Of Experiments (DOE) Applied To Pharmaceutical and Analytical QbD.
Design Of Experiments (DOE) Applied To Pharmaceutical and Analytical QbD.Design Of Experiments (DOE) Applied To Pharmaceutical and Analytical QbD.
Design Of Experiments (DOE) Applied To Pharmaceutical and Analytical QbD.SALMA RASHID SHAIKH
 
[2012] Empirical Evaluation on FBD Model-Based Test Coverage Criteria using M...
[2012] Empirical Evaluation on FBD Model-Based Test Coverage Criteria using M...[2012] Empirical Evaluation on FBD Model-Based Test Coverage Criteria using M...
[2012] Empirical Evaluation on FBD Model-Based Test Coverage Criteria using M...Donghwan Shin
 
Six Sigma Mechanical Tolerance Analysis 1
Six Sigma Mechanical Tolerance Analysis 1Six Sigma Mechanical Tolerance Analysis 1
Six Sigma Mechanical Tolerance Analysis 1David Panek
 
CDAC 2018 Pellegrini clustering ppi networks
CDAC 2018 Pellegrini clustering ppi networksCDAC 2018 Pellegrini clustering ppi networks
CDAC 2018 Pellegrini clustering ppi networksMarco Antoniotti
 
Optimization techniques
Optimization techniquesOptimization techniques
Optimization techniquesprashik shimpi
 
Design of Engineering Experiments Part 5
Design of Engineering Experiments Part 5Design of Engineering Experiments Part 5
Design of Engineering Experiments Part 5Stats Statswork
 
IRJET- Optimization of Plastic Injection Molding
IRJET- Optimization of Plastic Injection MoldingIRJET- Optimization of Plastic Injection Molding
IRJET- Optimization of Plastic Injection MoldingIRJET Journal
 
PF_MAO_2010_Souam
PF_MAO_2010_SouamPF_MAO_2010_Souam
PF_MAO_2010_SouamMDO_Lab
 
Optimizing chemical process through robust taguchi design a case study
Optimizing chemical process through robust taguchi design a case studyOptimizing chemical process through robust taguchi design a case study
Optimizing chemical process through robust taguchi design a case studyIAEME Publication
 
Csqe sample exam 1 solutions 05.00.04
Csqe sample exam 1   solutions 05.00.04Csqe sample exam 1   solutions 05.00.04
Csqe sample exam 1 solutions 05.00.04binodrit98
 
Use of Definitive Screening Designs to Optimize an Analytical Method
Use of Definitive Screening Designs to Optimize an Analytical MethodUse of Definitive Screening Designs to Optimize an Analytical Method
Use of Definitive Screening Designs to Optimize an Analytical MethodPhilip Ramsey
 
A Performance Study of BDD-Based Model Checking
A Performance Study of BDD-Based Model CheckingA Performance Study of BDD-Based Model Checking
A Performance Study of BDD-Based Model CheckingOlivier Coudert
 
Optimization techniques
Optimization techniquesOptimization techniques
Optimization techniquespradnyashinde7
 

Similar to Quality By Design (20)

DOE in Pharmaceutical and Analytical QbD.
DOE in  Pharmaceutical and Analytical QbD.DOE in  Pharmaceutical and Analytical QbD.
DOE in Pharmaceutical and Analytical QbD.
 
Qbd continued
Qbd continuedQbd continued
Qbd continued
 
Design Of Experiments (DOE) Applied To Pharmaceutical and Analytical QbD.
Design Of Experiments (DOE) Applied To Pharmaceutical and Analytical QbD.Design Of Experiments (DOE) Applied To Pharmaceutical and Analytical QbD.
Design Of Experiments (DOE) Applied To Pharmaceutical and Analytical QbD.
 
[2012] Empirical Evaluation on FBD Model-Based Test Coverage Criteria using M...
[2012] Empirical Evaluation on FBD Model-Based Test Coverage Criteria using M...[2012] Empirical Evaluation on FBD Model-Based Test Coverage Criteria using M...
[2012] Empirical Evaluation on FBD Model-Based Test Coverage Criteria using M...
 
Six Sigma Mechanical Tolerance Analysis 1
Six Sigma Mechanical Tolerance Analysis 1Six Sigma Mechanical Tolerance Analysis 1
Six Sigma Mechanical Tolerance Analysis 1
 
CDAC 2018 Pellegrini clustering ppi networks
CDAC 2018 Pellegrini clustering ppi networksCDAC 2018 Pellegrini clustering ppi networks
CDAC 2018 Pellegrini clustering ppi networks
 
Optimization techniques
Optimization techniquesOptimization techniques
Optimization techniques
 
Design of Engineering Experiments Part 5
Design of Engineering Experiments Part 5Design of Engineering Experiments Part 5
Design of Engineering Experiments Part 5
 
IRJET- Optimization of Plastic Injection Molding
IRJET- Optimization of Plastic Injection MoldingIRJET- Optimization of Plastic Injection Molding
IRJET- Optimization of Plastic Injection Molding
 
PF_MAO_2010_Souam
PF_MAO_2010_SouamPF_MAO_2010_Souam
PF_MAO_2010_Souam
 
gg_fall_15
gg_fall_15gg_fall_15
gg_fall_15
 
Optimizing chemical process through robust taguchi design a case study
Optimizing chemical process through robust taguchi design a case studyOptimizing chemical process through robust taguchi design a case study
Optimizing chemical process through robust taguchi design a case study
 
Csqe sample exam 1 solutions 05.00.04
Csqe sample exam 1   solutions 05.00.04Csqe sample exam 1   solutions 05.00.04
Csqe sample exam 1 solutions 05.00.04
 
Me 601-gbu
Me 601-gbuMe 601-gbu
Me 601-gbu
 
Use of Definitive Screening Designs to Optimize an Analytical Method
Use of Definitive Screening Designs to Optimize an Analytical MethodUse of Definitive Screening Designs to Optimize an Analytical Method
Use of Definitive Screening Designs to Optimize an Analytical Method
 
A Performance Study of BDD-Based Model Checking
A Performance Study of BDD-Based Model CheckingA Performance Study of BDD-Based Model Checking
A Performance Study of BDD-Based Model Checking
 
Optimization techniques
Optimization techniquesOptimization techniques
Optimization techniques
 
Response Surface.pptx
Response Surface.pptxResponse Surface.pptx
Response Surface.pptx
 
Robust Design
Robust DesignRobust Design
Robust Design
 
Facility Location
Facility Location Facility Location
Facility Location
 

Quality By Design

  • 1. Quality by Design Development, optimization and robustness by Design Mayank
  • 3. Global initiatives References 1. ICH, Q8(R1) Pharmaceutical Development (Geneva, Switzerland, Nov. 10, 2005; Rev. 2008). 2. ICH, Q9 Quality Risk Management (Geneva, Switzerland, Nov. 9. 2005). 3. J. Agalloco et al., "FDA's Guidance for Industry: Process Validation: General Principles and Practices," presented at PDA, Jan. 14, 2009. 4. FDA, Draft Guidance for Industry—Process Validation: General Principles and Practices (Rockville, MD, Nov. 2008). 5. W. Charlton, T. Ingallinera, and D. Shive, "Validation of Clinical Manufacturing," and Validation Chapter, in Validation of Pharmaceutical Process, J. Agalloco and F. Carleton, eds. (Informa Healthcare, New York, 3rd ed., 2008), pp. 542–544.
  • 4.
  • 10. Type of impurity (eg HCP, endotoxins, DNA,)
  • 11.
  • 15. Buffer conditions (eg pH, conductivity)
  • 20. pH
  • 22. DO
  • 26.
  • 31.
  • 41. LC/MS
  • 47. Quality by design (QbD) Process flow: Screening Characterization range Identification of significant parameters Acceptable range Finding parameter ranges Operating range Optimization Finding interactions of parameters Defining models Set point Validation Process design space Identification of CPP Identification of noise factors Process/ product Development: Robust Cost effective Feasible Defining control strategies Production Continuous monitoring and development
  • 48. Quality by design (QbD) Defining Design space
  • 49. Quality by design (QbD) Defining Design space
  • 50. Quality by design (QbD) Defining Design space
  • 51. Screening Parameter selection Physical Chemical Raw material Component/Equipment Process (time, type) Environmental Facility Categorical Continuous
  • 52. Screening Response Level selection Parameter Digging for a fossil
  • 55. Screening Fractional Factorial 23-1 C=AB C is confounding with AB
  • 56. Screening Fractional Factorial 23-1 C=AB C is confounding with AB B=AC B is confounding with AC
  • 57. Screening Fractional Factorial 23-1 C=AB C is confounding with AB B=AC B is confounding with AC A=BC A is confounding with BC
  • 58. Screening Fractional Factorial PlackettBurman 2 level fractional factorial designs Resolution III design Efficient estimations Interactions between factors ignored Used in Matrix form Multiple of 4 not power of 2 Saturated orthogonal array
  • 59. Screening Fractional Factorial PlackettBurman Matrix
  • 60. Screening Lack of fit Before deciding whether to build a response surface model, it is important to assess the adequacy of a linear model The error term ε in the model is comprised of two parts: modeling error, (lack of fit, LOF) experimental error, (pure error, PE), which can be calculated from replicate points The lack of fit test helps us determine if the modeling error is significant different than the pure error
  • 61. Screening Lack of fit Before deciding whether to build a response surface model, it is important to assess the adequacy of a linear model The error term ε in the model is comprised of two parts: modeling error, (lack of fit, LOF) experimental error, (pure error, PE), which can be calculated from replicate points The lack of fit test helps us determine if the modeling error is significant different than the pure error
  • 62. DOE and Experiments RS Model 1 x2 x1 Response surface methodology Input Response Black Boxed System Original System
  • 63. Response surface methodology RSM characteristics Models are simple polynomials Include terms for interaction and curvature Coefficients are usually established by regression analysis with a computer program Insignificant terms are discarded Model equation for 2 factors Y = β0constant + β1X1 + β2X2 main effects + β3X12 + β4X22 curvature + β5X1X2 interaction + ε error Model equation for 3 factors Y = β0constant + β1X1 + β2X2 + β3X3 main effects + β11X12 + β22X22 + β33X32 curvature + β12X1X2 + β13X1X3 + β23X2X3 interactions + ε error Higher order interaction terms are not included
  • 64. Response surface methodology Central composite design (CCD) eg. 2 factor Central composite circumscribed (CCC) 5 Levels α (star point) are beyond levels Central composite face centered (CCF) 3 Levels α (star point) are within levels (center) Central composite inscribed (CCI) 5 Levels α (star point) are within levels Scale down of CCC
  • 65. Response surface methodology Central composite design (CCD) Central composite circumscribed (CCC) 3 factors Total exp: 20 Full factorial 8 Axial points 6 Center points 6 +++ -+- --- +-- -++ ++- --+ +-+
  • 66. Response surface methodology Central composite design (CCD) Central composite circumscribed (CCC) Randomization: To avoid effect of uncontrollable nuisance variables +++ -+- --- +-- -++ ++- --+ +-+
  • 67. Response surface methodology Central composite design (CCD) Central composite circumscribed (CCC) Blocking: To avoid effect of controllable nuisance variables -++ +++ +-+ --+ ++- -+- +-- ---
  • 68.
  • 69. 3 levels of each factor is used
  • 70. Center points should be included
  • 71. It is possible to estimate main effects and second order terms
  • 72. Box-Behnken experiments are particularly useful if some boundary areas of the design region are infeasible, such as the extremes of the experiment regioneg. 3 factor 12 experiments
  • 73. Response surface methodology Comparison of RSM experiments * One third replicate is used for a 3k factorial design and one-half replicate is used for a 2k factorial design with the CCD for 5, 6 and 7 factors.
  • 74. Robust process development Who is better shooter? B A
  • 75. Robust process development Goal post vs Taguchi view LSL USL LSL USL
  • 76. Robust process development Reducing variation
  • 77. Robust process development Objective of robust process Smaller-the-Better S/N Ratio  = – 10 Log10 ( 1/n  Yi2 ) e.g. defects, impurity, process time, cost Larger-the-Better S/N Ratio  = – 10 Log10 ( 1/n  1/Yi2 ) e.g. titre, yield, resolution, profit Nominal-the-BestS/N Ratio  = – 10 Log10[1/n(YIDEAL- Yi ) 2 ] e.g. target Signal-to-Noise S/N Ratio =10log[μ2/σ2] e.g. trade-off
  • 78. Robust process development Identification of Signal and noise eg: Fermentation Signal: What can be controlled in plant and laboratory Noise: What can not be controlled in plant but in laboratory
  • 79. Robust process development Developing robust process To find a signal settings in presence of noise that minimize response variation while adjusting of keeping the process on target Taguchi approach Signal: Inner array Noise: Outer array